APP Acquisition of Fujisawa Generics Adds Manufacturing Capability
Executive Summary
American Pharmaceutical Partners will gain 560 employees and 94 product lines when it acquires Fujisawa USA's generics business (formerly Lyphomed) in a deal expected to close in May.